BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: David-Neto E, Triboni AH, Paula FJ, Vilas Boas LS, Machado CM, Agena F, Latif AZ, Alencar CS, Pierrotti LC, Nahas WC, Caiaffa-Filho HH, Pannuti CS. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients. Transplantation. 2014;98:1077-1081. [PMID: 24839894 DOI: 10.1097/tp.0000000000000189] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Requião-Moura LR. Local evidence on the cytomegalovirus viral load threshold for preemptive treatment is welcome, and a comment on indirect effects. J Bras Nefrol 2021;43:457-9. [PMID: 34747434 DOI: 10.1590/2175-8239-JBN-2021-E009] [Reference Citation Analysis]
2 Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroenterol 2019; 25(15): 1899-1906 [PMID: 31057303 DOI: 10.3748/wjg.v25.i15.1899] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rezzouk B, Bouattar T, Belkadi B, Razine R, Bayahia R, Ouzeddoun N, Benamar L, Rhou H, Bouihat N, Ibrahimi A, Seffar M, Kabbaj H. Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco. TRRM 2021;Volume 13:1-13. [DOI: 10.2147/trrm.s278655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Luciani L, Mongin D, Ninove L, Nougairède A, Bardy K, Gazin C, Charrel RN, Zandotti C. Cytomegalovirus Viral Load in Transplanted Patients Using the NeuMoDx™ (Qiagen) Automated System: A 1-Month Experience Feedback. Viruses 2021;13:1619. [PMID: 34452483 DOI: 10.3390/v13081619] [Reference Citation Analysis]
5 Lino K, Trizzotti N, Carvalho FR, Cosendey RI, Souza CF, Klumb EM, Silva AA, Almeida JR. Pp65 antigenemia and cytomegalovirus diagnosis in patients with lupus nephritis: report of a series. J Bras Nefrol. 2018;40:44-52. [PMID: 29796586 DOI: 10.1590/2175-8239-jbn-3838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Magistro G, Pilatz A, Schneede P, Schneidewind L, Wagenlehner F. [Viral infections in urology]. Urologe A 2021;60:1150-8. [PMID: 34228144 DOI: 10.1007/s00120-021-01589-3] [Reference Citation Analysis]
7 Santos SDRD, Bafi AT, Freitas FGR, Azevedo LCP, Machado FR. Prevalence of cytomegalovirus disease in kidney transplant patients in an intensive care unit. Rev Bras Ter Intensiva 2017;29:436-43. [PMID: 29340535 DOI: 10.5935/0103-507X.20170070] [Reference Citation Analysis]
8 Hellemans R, Wijtvliet V, Bergs K, Philipse E, Vleut R, Massart A, Couttenye MM, Matheeussen V, Abramowicz D. A split strategy to prevent cytomegalovirus after kidney transplantation using prophylaxis in serological high-risk patients and a pre-emptive strategy in intermediate-risk patients: Combining the best of two options? Transpl Infect Dis 2021;23:e13467. [PMID: 32935909 DOI: 10.1111/tid.13467] [Reference Citation Analysis]
9 Azevedo LS, Pierrotti LC, Abdala E, Costa SF, Strabelli TM, Campos SV, Ramos JF, Latif AZ, Litvinov N, Maluf NZ, Caiaffa Filho HH, Pannuti CS, Lopes MH, Santos VA, Linardi Cda C, Yasuda MA, Marques HH. Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo). 2015;70:515-523. [PMID: 26222822 DOI: 10.6061/clinics/2015(07)09] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 13.7] [Reference Citation Analysis]